Dr. F. Harig
www.dr-harig.de
HomePersönliche DatenBerufliche LaufbahnKontaktBildergalerie
Abstracts
Vorträge und Poster
Buchbeiträge, etc.
Abstracts

Zitierfähige  Kurzfassungen

  1. Mitrou PS, Grieser H, Harig F, Andreesen R, Bergmann L:
    Kinetics of TNF-a     and IFN-g production in vitro and in vivo induced by
    Interleukin-2 (IL-2).
    Blood 1989; 59: 310
  2. Weidmann E, Bergmann L, Hechler P, Grieser H, Harig F, Mitrou PS. 
    Kinetics of Cytokine Release after Therapy of Advanced Cancer Patients
    with Interleukin‑2 (IL-2) as Bolus Injection or Continuous Infusion and under
    in vitro Activation of Mononuclear Cells with IL-2.
    Frankfurt International Interleukin Symposium.
    Frankfurt a.M., FRG, March 23-24, 1990.
    Nat Immun Cell Growth Regul. 1990; 9(2): 61-90.
    PMID: 2352540 [PubMed - indexed for MEDLINE]
  3. F. Harig, B. Hohenstein, J. Riese, W. Haupt, J. von der Emde.
    Immunomonitoring during and after CPB for analysis of cytokine secretion
    patterns and developing of a preventive strategy of SIRS after Cardiac
    Surgery.
    Thorac Cardiovasc Surg. 1997; 45 (Suppl.I): 65, 138 (50)
  4. R. Feyrer, R. Cesnjevar, F. Harig, J. Rösch, von der Emde J.
    Bioimpedance analysis: a simple method for estimation of pre-, intra- and
    postoperative hydration status following cardiac surgery.
    Thorac Cardiovascular Surg. 1998; 46 (Suppl.I): 106, 194 (109P)
  5. F. Harig, R. Feyrer, F.O. Mahmoud, U. Blum, J. von der Emde. 
    Reducing the post- pump- Syndrome by using heparin- coated circuits,
    steroids and trasylol® .
    Thorac Cardiovasc Surg. 1998; 46 (Suppl.I): 81, 170 (52)
  6. Harig F, Hohenstein B, von der Emde J:  
    Correlation of cytokine release after cardio-pulmonary bypass with clinical
    parameters (APACHE II- score) in patients with normal LV-function?
    Thorac Cardiovasc Surg. 1998; 46 (Suppl.I): 132, 219 (173P)
  7. Harig F, Cesnjevar R, Mahmoud FO, von der Emde J:
    Perioperative factors influencing Interleukin-10-release under CPB.
    Thorac Cardiovascular Surg. 1999; 47 (Suppl.I): 101, 216 (95)
  8. R. Cesnjevar, Y. Lindemann, R. Feyrer, F. Walther, F. Harig, P. Mauser-
    Weber, F.O. Mahmoud, J. von der Emde.  
    Mitral valve replacement with Starr-Edwards- low-profile prothesis – 
    Results after more than 25 years.
    Thorac Cardiovasc Surg. 1999; 47 (Suppl.1): 78, 193 (44P)
  9. Harig F, Hohenstein B, Weyand M. 
    Modulating IL-6 and IL-10 levels by pharmacologic and ECC- strategies
    during cardiac surgery.
    Shock 2000; Vol 13, Suppl.1.: 31
  10. Harig F, Cesnjevar R, Lindemann Y, Bumiller L, Singer H, Weyand M:
    Phosphorylcholine- coated cradiopulmonary bypass in paediatric cardiac
    surgery improves biocompatibility: reduced contact activation and
    endothelin-1 release.
    Critical Care 2001, 5:112 Volume 5 Suppl B
  11. Harig F, Mahmoud FO, Cesnjevar R, Feyrer R, Fischlein T, Weyand M.
    30 years experience with surgical treatment of left ventricular aneurysms.
    Thorac Cardiovasc Surg. 2001; 47 (Suppl.1): OP76
  12. Seitz T, Cesnjevar R, Harig F, Fischlein T, Weyand M.    
    Oral Calcium Binding Citrate Reduces Aortic Tissue Calcification after Heterotopic
    Aortic Valve Implantation in Rats.
    Thorac Cardiovasc Surg. 2001; 47 (Suppl.1): PP 11
  13. Harig F, Cesnjevar R, Feyrer R, Reimann A, Bumiller L, Strasser E, Singer H, Weyand M.
    Modulation of Platelet Activation by Phospholipid Coating of ECC in Pediatric Cardiac Surgery.
    Thorac Cardiov Surg 2002; 50(Suppl.1): S51
  14. E.Schoof, A.Stuppy, F.Harig, M.Gröschl, H.Singer; M. Weyand, W. Rascher, J. Dötsch.  Leptin gene expression in adipose tissue after cardiac surgery in adults and infants.
    Experimental and Clinical Endocrinology & Diabetes 2001;86(11): 5234
  15.  Harig F, Cesnjevar R, Feyrer R, Reimann A, Bumiller L, Strasser E, Singer H,  Weyand M: 
    Phospholipid Coating of ECC attenuates Platelet Activation in Pediatric Cardiac Surgery.
    Cardiovasc Engineering (CVE) 2002;Vol. 7, No. 1: 34-35 [ISSN 1432-9077]
  16.  R. Feyrer, F. Harig, R. Cesnjevar, F. Mahmoud, T. Fischlein, M. Doreth, M. Weyand. 
    Variations of Body Composition by Bioelectric Impedance Analysis after CABG using Heparin Coated and Protein Treated Bypass Circuits. 
    Cardiovasc Engineering (CVE) 2002;Vol. 7, No. 1: 21 [ISSN 1432-9077]
  17. F.Harig, R.Cesnjevar, R.Feyrer, A.Reimann, L.Bumiller, R.Strasser, H.Singer, M.Weyand.  Modulation der Thrombozytenaktivierung durch Phospholipidbeschichtung der EKZ in der  Kinderherzchirurgie. 
    Zeitschrift für Kardiologie 2002;91: 740
  18.  R. Feyrer, F. Harig, R. Cesnjevar, O. Faidi Mahmoud,  M. Doreth, M. Weyand.
    Variations of Body Composition by Bioelectric Impedance Analysis after CABG using Heparin Coated and Protein Treated Bypass Circuits.
    Cardiovasc Engineering (CVE) 2002;Vol. 7, No. 1: 21 [ISSN 1432-9077]
  19. R.Feyrer, F. Harig, R. Cesnjevar, O. F.Mahmoud, H. Parsch, M. Doreth,  M. Weyand.      Heparin- coating or protein treatment of CPB- Circuits: Is there any difference in the inflammatory response?
    Thorac Cardiov Surg 2002; 50(Suppl.1): S61
  20. Reimann A, Cesnjevar R, Harig F, Ensminger S, Metzler-Bertram U, Weyand M.           Corrective aortic arch surgery in children using continous hypothermic “low flow perfusion” as an alternative to deep hypothermic circulatory arrest.
    Thorac Cardiov Surg 2003; 52(Suppl.1): S53 (10617)
  21. R. Feyrer, F. Harig, R. Cesnjevar, O. Faidi Mahmoud, H. Parsch, M. Doreth, T. Fischlein, M. Weyand. Bioline or Safeline Treatment of CPB Circuits?
    Cardiovasc Engineering (CVE) 2003; Vol.8, No. 1-2: 79-84
  22. Richard Feyrer, Frank Harig, Robert Cesnjevar O. Faidi Mahmoud, M. Doreth,  Michael Weyand. Bioelectrical Impedance Analysis in Cardiac Surgery.
    The Internet Journal of Thoracic and Cardiovascular Surgery.2003. Vol.5 No.2
  23. R. Feyrer, U. Kunzmann, F. Harig, J. Rösch, M. Weyand. 
    The use of a clinical pathway as a cost unit in cardiac surgery.
    J  Cardiovascular Surgery 2005; 45(3): Suppl.1: O002 (145)
  24. R. Feyrer, J. Bretzger, F. Harig, R. Cesnjevar, M. Weyand.
    Cost reduction in   cardiac surgery by structured cost analysis in cardiovascular engineering. 
    J Cardiovascular Surgery 2005; 45(3): Suppl.1: O004 (145)
  25. F. Harig, C. Meier, L. Hakami, R. Strasser, J. Bretzger, F. Münch, E. Vestweber- Wilmes, H. Singer, M. Weyand and R. Cesnjevar. 
    Does the Additional Use of Heparin-coated Extracorporeal Circuits (ECC) Optimize the Effect of Modified Ultrafiltration (MUF) in Pediatric Perfusion?
    Thorac Cardiov Surg 2005; 54 [DOI: 10.1055/s-2006-925706]
  26. F Harig, I Fraunholz-Meisinger, M Groeschl, J Doetsch, W Rascher, M Weyand.   Postoperative course of metabolic hormones leptinand ghrelin in adults after on pump coronary Artery Bypass Grafting.                                                            Thorac Cardiov Surg 2005; 53 [DOI: 10.1055/s-2005-862106]
  27. M Ledwon, F Harig, M Weyand.                                           
    The decrease of degeneration rate by means of a permanent antithrombotic therapy 16 and more years after the biological aortic valve replacement.
    Thorac cardiovasc Surg 2006; 54 [DOI: 10.1055/s-2006-925706]
  28. H Görler, A Haverich, PRIMO-Investigators CABG (F Harig, M Weyand, et al.). 
    Pexelizumab, a new complement inhibitor, reduces death and myocardial infarction in patients with moderate and severe heart failure: Results from the PRIMO-CABG trial.   
    Thorac cardiovasc Surg 2006; 54 [DOI: 10.1055/s-2006-925593]
  29. S Abele, M Wollin, N Hiemann, F Harig, T Fischlein, M Weyand, S Ensminger. 
    Clopidogrel (Plavix®) significantly reduced the development of transplant arteriosclerosis in murine aortic allografts.
    Thorac cardiovasc Surg 2006; 54 [DOI: 10.1055/s-2006-925869]
  30. R Feyrer; U Kunzmann; M Weyand; F Harig.
    ICU costs in cardiac surgery.
    Thorac cardiovasc Surg 2007; 55 [DOI: 10.1055/s-2007-967664]
  31. F Harig; J Rösch; FO Mahmoud; M Weyand; R Feyrer.
    Tranexamic acid shows equivalent effects and reduces costs compared to aprotinin.
    Thorac cardiovasc Surg 2007; 55 [DOI: 10.1055/s-2007-967460]
  32. F.Harig, J. Schmidt, E.Hoyer, D.Labahn, K. Amman, M. Weyand, S.M.Ensminger. Selective arterializationof V. cordis magna (retrobypass) prevents hemodynamic instability after LAD-occlusionin a porcine long term model.                            Thorac cardiovasc Surg 2009; 56                                                                     DOI: 10.1055/s-0029-1191686
     

Alle Rechte vorbehalten.